CO6862153A2 - Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv) - Google Patents

Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv)

Info

Publication number: CO6862153A2
Authority: CO; Colombia
Prior art keywords: hcv; hepatitis; infections; virus; treatment
Prior art date: 2011-08-19

Application number

CO14013113A

Other languages

English (en)

Inventor

Pek Yoke Chong

John F Miller

Andrew James Peat

John Brad Shotwell

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-08-19

Filing date

2014-01-23

Publication date

2014-02-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47746761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6862153(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-01-23 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2014-02-10 Publication of CO6862153A2 publication Critical patent/CO6862153A2/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

CO14013113A 2011-08-19 2014-01-23 Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv) CO6862153A2 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161525440P	2011-08-19	2011-08-19
US201261650681P	2012-05-23	2012-05-23

Publications (1)

Publication Number	Publication Date
CO6862153A2 true CO6862153A2 (es)	2014-02-10

Family

ID=47746761

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CO14013113A CO6862153A2 (es)	2011-08-19	2014-01-23	Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv)

Country Status (38)

Country	Link
US (2)	US8927593B2 (es)
EP (2)	EP2744332B1 (es)
JP (2)	JP6367712B2 (es)
KR (1)	KR101913800B1 (es)
CN (1)	CN103732065B (es)
AR (1)	AR087563A1 (es)
AU (1)	AU2012299295B2 (es)
BR (1)	BR112014002845A2 (es)
CA (1)	CA2844086A1 (es)
CL (2)	CL2014000393A1 (es)
CO (1)	CO6862153A2 (es)
CR (1)	CR20140078A (es)
CY (1)	CY1118399T1 (es)
DK (1)	DK2744332T3 (es)
DO (1)	DOP2014000034A (es)
EA (1)	EA032841B1 (es)
ES (1)	ES2611731T3 (es)
HR (1)	HRP20161743T1 (es)
HU (1)	HUE030300T2 (es)
IL (1)	IL230487B (es)
IN (1)	IN2014CN00572A (es)
JO (1)	JO3281B1 (es)
LT (1)	LT2744332T (es)
MA (1)	MA35443B1 (es)
ME (1)	ME02588B (es)
MX (1)	MX354676B (es)
PE (1)	PE20141201A1 (es)
PH (1)	PH12014500385A1 (es)
PL (1)	PL2744332T3 (es)
PT (1)	PT2744332T (es)
RS (1)	RS55462B1 (es)
SG (1)	SG10201606883QA (es)
SI (1)	SI2744332T1 (es)
SM (2)	SMT201700028T1 (es)
TW (1)	TWI538915B (es)
UY (1)	UY34274A (es)
WO (1)	WO2013028371A1 (es)
ZA (1)	ZA201401020B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103929965B (zh) *	2011-08-17	2016-08-17	葛兰素史克有限责任公司	治疗方法
RS55462B1 (sr)	2011-08-19	2017-04-28	Glaxo Group Ltd	Jedinjenja benzofurana za tretiranje infekcija sa virusom hepatitisa c
BR112017009501A2 (pt) *	2014-11-10	2018-02-06	Glaxosmithkline Ip No 2 Ltd	método para tratar uma infecção por hcv, método para curar uma infecção por hcv, e, composição farmacêutica.
EP3218486A1 (en) *	2014-11-10	2017-09-20	Glaxosmithkline Intellectual Property (No. 2) Limited	Combination long acting compositions and methods for hepatitis c
KR20180006522A (ko)	2016-07-07	2018-01-18	삼성디스플레이 주식회사	액정 조성물 및 이를 포함하는 액정 표시 장치
US11738088B2 (en)	2016-08-01	2023-08-29	University of Pittsburgh—of the Commonwealth System of Higher Education	Boryl ethers, carbonates, and cyclic acetals as oxidatively-triggered drug delivery vehicles
AU2018227811A1 (en) *	2017-03-02	2019-09-19	Assembly Biosciences, Inc.	Cyclic sulfamide compounds and methods of using same
JP7133023B2 (ja) *	2018-01-17	2022-09-07	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド	Ｐｉ４ｋｉｉｉベータ阻害剤
JP7654554B2 (ja) *	2019-10-25	2025-04-01	住友ファーマ株式会社	新規置換縮環型化合物
CN111026203B (zh) *	2019-12-02	2021-01-26	宁波德晶元科技有限公司	一种适用于真空热水壶的加热控制方法与系统

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
CA2376965A1 (en) *	1999-07-07	2001-01-11	Timothy Patrick Forsyth	Peptide boronic acid inhibitors of hepatitis c virus protease
EP2251344B2 (en)	2001-01-25	2024-04-24	THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Formulation of boronic acid compounds
CN1731993A (zh)	2002-11-01	2006-02-08	维洛药品公司	苯并呋喃化合物、组合物以及治疗和预防丙型肝炎病毒感染及相关疾病的方法
WO2008051244A2 (en)	2005-12-01	2008-05-02	Wyeth	Anthranilic acid derivatives useful in treating infection with hepatitis c virus
DK1988779T5 (en)	2006-02-16	2016-10-10	Anacor Pharmaceuticals Inc	SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS
BRPI0711155A2 (pt) *	2006-05-02	2011-08-23	Anacor Pharmaceuticals Inc	terapêuticos contendo boro resistentes hidroliticamente e métodos de uso
US20070286822A1 (en)	2006-06-12	2007-12-13	Anacor Pharmaceuticals Inc.	Compounds for the Treatment of Periodontal Disease
EP2520561B1 (en) *	2007-06-08	2016-02-10	MannKind Corporation	IRE-1A Inhibitors
GB0719366D0 (en) *	2007-10-03	2007-11-14	Smithkline Beecham Corp	Compounds
EP2245023B1 (en)	2008-02-14	2011-12-28	F. Hoffmann-La Roche AG	Heterocyclic antiviral compounds
EP2187893A4 (en)	2008-03-06	2012-02-22	Anacor Pharmaceuticals Inc	SMALL BORON-CONTAINING MOLECULES AS ANTI-INFLAMMATORY AGENTS
WO2009137493A1 (en)	2008-05-05	2009-11-12	Wyeth	2-substituted benzofuran compounds to treat infection with hepatitis c virus
WO2009137500A1 (en)	2008-05-05	2009-11-12	Wyeth	6-substituted benzofuran compounds to treat infection with hepatitis c virus
US7737157B2 (en)	2008-08-29	2010-06-15	Hutchison Medipharma Enterprises Limited	Pyrimidine compounds
WO2010027975A1 (en)	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2011050284A1 (en) *	2009-10-23	2011-04-28	Glaxosmithkline Llc	Pyrazolylpyridine antiviral agents
TW201138786A (en)	2010-02-19	2011-11-16	Glaxo Group Ltd	Therapeutic compounds
WO2011106929A1 (en)	2010-03-02	2011-09-09	Merck Sharp & Dohme Corp.	Inhibitors of hepatitis c virus ns5b polymerase
AR080433A1 (es)	2010-03-02	2012-04-11	Merck Sharp & Dohme	Derivados de benzofurancarboxamidas utiles para tratar o prevenir infecciones por vhc y composiciones farmaceuticas que los contienen.
WO2011106986A1 (en)	2010-03-02	2011-09-09	Merck Sharp & Dohme Corp.	Inhibitors of hepatitis c virus ns5b polymerase
AU2011329486A1 (en)	2010-11-18	2013-04-18	Glaxo Group Limited	Compounds
WO2012067663A1 (en)	2010-11-18	2012-05-24	Glaxo Group Limited	Compounds
WO2013025975A1 (en) *	2011-08-17	2013-02-21	Glaxosmithkline Llc	Combination treatments for hepatitis c
CN103929965B (zh) *	2011-08-17	2016-08-17	葛兰素史克有限责任公司	治疗方法
RS55462B1 (sr)	2011-08-19	2017-04-28	Glaxo Group Ltd	Jedinjenja benzofurana za tretiranje infekcija sa virusom hepatitisa c

2012
- 2012-08-10 RS RS20161131A patent/RS55462B1/sr unknown
- 2012-08-10 MX MX2014001989A patent/MX354676B/es active IP Right Grant
- 2012-08-10 SI SI201230826A patent/SI2744332T1/sl unknown
- 2012-08-10 ES ES12826498.3T patent/ES2611731T3/es active Active
- 2012-08-10 AU AU2012299295A patent/AU2012299295B2/en not_active Ceased
- 2012-08-10 CN CN201280040219.3A patent/CN103732065B/zh not_active Expired - Fee Related
- 2012-08-10 DK DK12826498.3T patent/DK2744332T3/en active
- 2012-08-10 LT LTEP12826498.3T patent/LT2744332T/lt unknown
- 2012-08-10 WO PCT/US2012/050268 patent/WO2013028371A1/en not_active Ceased
- 2012-08-10 ME MEP-2016-287A patent/ME02588B/me unknown
- 2012-08-10 EA EA201490213A patent/EA032841B1/ru not_active IP Right Cessation
- 2012-08-10 BR BR112014002845A patent/BR112014002845A2/pt not_active Application Discontinuation
- 2012-08-10 US US13/885,500 patent/US8927593B2/en not_active Expired - Fee Related
- 2012-08-10 SM SM20170028T patent/SMT201700028T1/it unknown
- 2012-08-10 PL PL12826498T patent/PL2744332T3/pl unknown
- 2012-08-10 SG SG10201606883QA patent/SG10201606883QA/en unknown
- 2012-08-10 HR HRP20161743TT patent/HRP20161743T1/hr unknown
- 2012-08-10 PE PE2014000197A patent/PE20141201A1/es not_active Application Discontinuation
- 2012-08-10 PH PH1/2014/500385A patent/PH12014500385A1/en unknown
- 2012-08-10 CA CA2844086A patent/CA2844086A1/en not_active Abandoned
- 2012-08-10 KR KR1020147007196A patent/KR101913800B1/ko not_active Expired - Fee Related
- 2012-08-10 HU HUE12826498A patent/HUE030300T2/en unknown
- 2012-08-10 PT PT128264983T patent/PT2744332T/pt unknown
- 2012-08-10 EP EP12826498.3A patent/EP2744332B1/en active Active
- 2012-08-10 EP EP16195408.6A patent/EP3199531A1/en not_active Withdrawn
- 2012-08-10 IN IN572CHN2014 patent/IN2014CN00572A/en unknown
- 2012-08-10 JP JP2014526090A patent/JP6367712B2/ja not_active Expired - Fee Related
- 2012-08-16 AR ARP120103008A patent/AR087563A1/es unknown
- 2012-08-16 JO JOP/2012/0233A patent/JO3281B1/ar active
- 2012-08-17 TW TW101130017A patent/TWI538915B/zh not_active IP Right Cessation
- 2012-08-17 UY UY0001034274A patent/UY34274A/es not_active Application Discontinuation
2014
- 2014-01-16 IL IL230487A patent/IL230487B/en not_active IP Right Cessation
- 2014-01-23 CO CO14013113A patent/CO6862153A2/es active IP Right Grant
- 2014-02-10 ZA ZA201401020A patent/ZA201401020B/en unknown
- 2014-02-17 CL CL2014000393A patent/CL2014000393A1/es unknown
- 2014-02-18 CR CR20140078A patent/CR20140078A/es unknown
- 2014-02-19 DO DO2014000034A patent/DOP2014000034A/es unknown
- 2014-03-13 MA MA36832A patent/MA35443B1/fr unknown
- 2014-11-20 US US14/548,524 patent/US9682999B2/en not_active Expired - Fee Related
2016
- 2016-12-22 JP JP2016249387A patent/JP2017125010A/ja active Pending
- 2016-12-27 CY CY20161101345T patent/CY1118399T1/el unknown
2017
- 2017-01-18 SM SM201700028T patent/SMT201700028B/it unknown
- 2017-02-03 CL CL2017000293A patent/CL2017000293A1/es unknown

Also Published As

Publication number	Publication date
IN2014CN00572A (es)	2015-04-03
JO3281B1 (ar)	2018-09-16
EP2744332B1 (en)	2016-10-26
PH12014500385A1 (en)	2020-06-22
TWI538915B (zh)	2016-06-21
CL2014000393A1 (es)	2014-08-01
TW201321390A (zh)	2013-06-01
MX2014001989A (es)	2014-02-27
IL230487B (en)	2019-06-30
JP6367712B2 (ja)	2018-08-01
CL2017000293A1 (es)	2017-10-06
US20150080343A1 (en)	2015-03-19
KR20140054287A (ko)	2014-05-08
HUE030300T2 (en)	2017-04-28
BR112014002845A2 (pt)	2017-02-21
CN103732065A (zh)	2014-04-16
JP2014527529A (ja)	2014-10-16
RS55462B1 (sr)	2017-04-28
DK2744332T3 (en)	2017-01-16
AU2012299295A1 (en)	2014-02-20
PE20141201A1 (es)	2014-10-03
KR101913800B1 (ko)	2018-11-01
US9682999B2 (en)	2017-06-20
SMT201700028B (it)	2017-03-08
SI2744332T1 (sl)	2017-01-31
PL2744332T3 (pl)	2017-03-31
CR20140078A (es)	2014-03-20
HRP20161743T1 (hr)	2017-02-24
EA201490213A1 (ru)	2014-07-30
LT2744332T (lt)	2017-01-10
EP2744332A1 (en)	2014-06-25
AU2012299295B2 (en)	2016-03-31
PT2744332T (pt)	2017-01-24
MX354676B (es)	2018-03-15
SG10201606883QA (en)	2016-10-28
SMT201700028T1 (it)	2017-03-08
UY34274A (es)	2013-04-05
IL230487A0 (en)	2014-03-31
DOP2014000034A (es)	2014-06-01
EP3199531A1 (en)	2017-08-02
EP2744332A4 (en)	2015-01-14
EA032841B1 (ru)	2019-07-31
CA2844086A1 (en)	2013-02-28
CY1118399T1 (el)	2017-06-28
MA35443B1 (fr)	2014-09-01
JP2017125010A (ja)	2017-07-20
ZA201401020B (en)	2020-11-25
AR087563A1 (es)	2014-04-03
ES2611731T3 (es)	2017-05-10
US8927593B2 (en)	2015-01-06
ME02588B (me)	2017-06-20
CN103732065B (zh)	2016-10-26
WO2013028371A1 (en)	2013-02-28
US20130237501A1 (en)	2013-09-12

Publication	Publication Date	Title
CO6862153A2 (es)	2014-02-10	Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv)
SMT201600325B (it)	2016-11-10	Alifani, ciclofani, eterafani, eterofani, etero-eterafani e metalloceni sostituiti utili per il trattamento di infezioni da hcv
DK3590928T3 (da)	2021-08-30	Pyrimidinderivater til behandling af virusinfektioner
CL2015000482A1 (es)	2015-07-10	Compuestos derivado de 6-aminoacido-heteriarildihidropirimidinas; proceso de obtención; composicion farmaceutica; y su uso para el tratamiento o profilaxis de la infección por el virus de la hepatitis b
IL232046A0 (en)	2014-05-28	Purine derivatives for the treatment of viral infections
CL2013001428A1 (es)	2014-06-27	Compuesto que inhibe la actividad del virus de la hepatitis c (hcv); composición farmacéutica que comprende el compuesto; método de tratamiento de hepatitis c.
HUE057928T2 (hu)	2022-06-28	Coronaviridae családba tartozó vírus okozta fertõzések kezelésére szolgáló eljárások
CL2015000925A1 (es)	2015-08-28	Compuestos derivados de heterociclos nitrogenados; composicion farmaceutica; un metodo para tratar infecciones viricas provocadas por virus sincicial respiratorio (vsr)
UA116087C2 (uk)	2018-02-12	Композиція для лікування вірусу гепатиту c
ZA201501018B (en)	2019-07-31	Compounds for the treatment of paramoxyvirus viral infections
DK2958900T3 (da)	2019-07-01	2-aminopyrimidinderivater til behandling af virusinfektioner
CO6821947A2 (es)	2013-12-31	Inhibidores del virus de la hepatitis c
BR112013012998A2 (pt)	2016-09-13	compostos para tratar infecções por vírus sincicial respiratório
CO6940424A2 (es)	2014-05-09	Inhibidores del virus de la hepatitis c
CO6821952A2 (es)	2013-12-31	Inihibidores del virus de la hepatitis c
DK2939665T3 (da)	2019-06-11	Farmaceutisk sammensætning til behandling af hiv-infektioner
EP2756102A4 (en)	2015-04-15	DETECTION OF VIRAL INFECTION
IL232393A0 (en)	2014-06-30	Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
CL2014000394A1 (es)	2014-08-01	Uso de compuestos fenil-benzofuran-sulfamido sustituidos para el tratamiento del virus de la hepatitis c (hcv); y composicion farmaceutica que comprende a estos compuestos fenil-benzofuran-sulfamido sustituidos.
EP2900656A4 (en)	2016-03-02	SPIRRING COMPOUNDS AS HEPATITIS C-VIRUS (HCV) INHIBITORS
DK2723336T3 (da)	2020-06-29	Sammensætninger til behandling af fragilt X-syndrom
CO6801768A2 (es)	2013-11-29	Procesos para la preparación de inhibidores del virus de la hepatitis
BR112013011405A2 (pt)	2016-08-02	composição farmacêutica para tratar infecções por hcv
ZA201306342B (en)	2014-04-30	The treatment of viral infections
BR112013025021A2 (pt)	2017-03-01	alisporivir para tratar infecções por vírus de hepatite c.

Legal Events

Date	Code	Title	Description
2015-06-30	FG	Application granted